co11ab co-hosted a dynamic panel discussion featuring leaders from Cedars-Sinai and 𝗖𝗼𝗿𝗼𝗻𝗲𝘁 𝗩𝗲𝗻𝘁𝘂𝗿𝗲𝘀, as they shared timely insights on emerging trends and strategic investments in the U.S. health tech ecosystem.

The lively discussion was further enriched by our moderator, Clarice Chen from Enterprise Singapore, whose charismatic and impactful facilitation helped the audience better understand Cedars-Sinai’s capabilities and key focus areas, including regenerative medicine, biomanufacturing, and clinical trials.

Cedars-Sinai’s growing presence in Singapore reflects their confidence in our vibrant healthtech and biomedtech landscape. Together with our founding partners, co11ab is proud to play a catalytic role in connecting global and local players through strategic partnerships and impactful programming.

As we continue to strengthen our ecosystem locally and internationally, we look forward to more meaningful collaborations to help startups grow, scale, and succeed.

Thank you to our speakers:
💠Nirdesh K Gupta, PhD Gupta (Managing Partner, Cedars-Sinai & CEO Coronet Ventures)
💠Colin Tan (Investment Director, Coronet Ventures)
💠Wenyue Du, PhD, CLP (Director of Business Development – Biomedical, Cedars-Sinai)
💠Julien Brohan (Director of Business Development – Medtech, Cedars-Sinai)
💠Clarice Chen (Director of Healthcare & Biomedical, Enterprise Singapore)